D'Amore, F. A., Gaulard, P., Trümper, L., Corradini, P., Kim, W.-S., Specht, L.
& Pedersen, M. B. (2014).
T-cell lymphoma:L ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow up.
Annals of Oncology.
D'Amore, F. A., Jørgensen, J. M., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulcynski, E., Pedersen, B., Gillstrom, D., Clausen, M. R.
, Kamper, P., Silkjær, T., Gormsen, L. C., Leppä, S.
& Toldbod, H. (2014).
Preliminary clinical experience on the efficacy and feasibility of a new combination regimen consisting of pixantrone, etoposide and bendamustine with or without the addition of rituximab in patients with relapsed/refractory aggressive non-hodgkin lymphomas.
Blood,
124(21).
D'Amore, F. A., Relander, T., Lauritzen, G. F., Jantunen, E., Mannisto, S., Meyer, P., Ellin, F.
, Pedersen, M. B. & Toldbod, H. (2016).
Hematopoietic stem-cell transplantation in peripheral T-cell lymphomas. In
Hematopoietic cell transplants - Concepts, controversies and future directions Cambridge University Press.
d'Amore, F. A., Johansen, P., Houmand, A., Weisenburger, DD. & Mortensen, L. (1996).
Epstein-Barr virus genome in non-Hodgkin's lymphomas occuring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO. Blood,
87((3)), 1045-55.
d'Amore, F. A., Stribley, JA., Ohno, T., Wu, G., Wickert, RS., Delabie, J., Hinrichs, SH. & Chan, W. C. (1997).
Molecular studies on single cells harvested by micromanipulation from archival tissue sections previously stained by immunohistochemistry or nonisotopic in situ hybridization.
Laboratory Investigation,
76((2)), 219-24.
d'Amore, F., Radford, J., Relander, T., Jerkeman, M., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H. (2010).
Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma.
British Journal of Haematology, Supplement,
150(5), 565-73.
https://doi.org/10.1111/j.1365-2141.2010.08298.x
d'Amore, F., Gaulard, P., Trümper, L., Corradini, P.
, Kim, W.-S., Specht, L., Bjerregaard Pedersen, M., Ladetto, M. & ESMO Guidelines Committee (2015).
Peripheral T-cell Lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of Oncology,
26 Suppl 5, v108-15.
https://doi.org/10.1093/annonc/mdv201
Coiffier, B., Federico, M., Caballero, D., Dearden, C., Morschhauser, F., Jäger, U., Trümper, L., Zucca, E., Gomes da Silva, M., Pettengell, R., Weidmann, E.
, d'Amore, F., Tilly, H. & Zinzani, P. L. (2014).
Therapeutic options in relapsed or refractory peripheral T-cell lymphoma.
Cancer Treatment Reviews,
40(9), 1080-1088.
https://doi.org/10.1016/j.ctrv.2014.08.001
Clausen, M. R., Leppa, S., Brown, P. D. N., Goerloev, J. S., Panny, M., Willenbacher, W., Sillesen, I. B., Segel, E., Bentzen, H. H. N., Thorsgaard, M., Pulczynski, E. J.
, Kamper, P., Gormsen, L. C., Mortensen, J., Lauritzsen, G., Relander, T.
& d'Amore, F. (2016).
The Combination of Pixantrone, Etoposide, Bendamustine and, in CD20+ Tumors, Rituximab (PREBEN) Shows Promising Feasibility/Efficacy in Heavily Pre-Treated Aggressive Lymphomas of B- and T-Cell Phenotype - Results of the Pre-Trial Experience Leading to a Nordic Phase 1/2 Study (the PREBEN Trial).
Blood,
128(22), 1782-1782.
http://www.bloodjournal.org/content/128/22/1782
Clausen, M. R.
, Ulrichsen, S. P., Larsen, T. S., Poulsen, C. B., Tojaga, S., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S., Nørgaard, M.
& d'Amore, F. (2019).
Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study.
Leukemia and Lymphoma,
60(8), 1950-1957.
https://doi.org/10.1080/10428194.2018.1554863
Clausen, M. R., Maurer, M. J.
, Ulrichsen, S. P., Larsen, T. S., Himmelstrup, B., Rønnov-Jessen, D., Link, B. K., Feldman, A. L., Slager, S. L., Nowakowski, G. S., Thompson, C. A., Pedersen, P. T., Madsen, J., Pedersen, R. S., Gørløv, J. S., Cerhan, J. R.
, Nørgaard, M. & D’amore, F. (2019).
Pretreatment hemoglobin adds prognostic information to the nccn-ipi in patients with diffuse large b-cell lymphoma treated with anthracycline-containing chemotherapy.
Clinical epidemiology,
11, 987-996.
https://doi.org/10.2147/CLEP.S219595
Clausen, M. R.
, Ulrichsen, S. P., Juul, M. B., Poulsen, C. B., Iversen, B., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S.
, Nørgaard, M. & d'Amore, F. (2020).
Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study.
Hematological Oncology,
38(3), 318-325.
https://doi.org/10.1002/hon.2734
Christensen, M. S., Hansen, J.
, Ramlau-Hansen, C., Toft, G., d'Amore, F. & Kolstad, H. A. (2014).
0177 Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry.
Occupational & Environmental Medicine,
71 Suppl 1, A82-3.
https://doi.org/10.1136/oemed-2014-102362.257
Christensen, M. H., Hansen, J., Ramlau-Hansen, C., Toft, G.
, D'Amore, F. A. & Kolstad, H. (2014).
Exposure to styrene and the risk of cancer: a long-term follow-up study of workers in the Danish reinforced plastics industry. Occupational & Environmental Medicine,
71(Suppl 1).
Christensen, B.
, Ludvigsen, M., Nellemann, B., Kopchick, J. J.
, Honoré, B. & Jørgensen, J. O. L. (2015).
Serum Proteomic Changes after Randomized Prolonged Erythropoietin Treatment and/or Endurance Training: Detection of Novel Biomarkers.
PLOS ONE,
10(2), e0117119.
https://doi.org/10.1371/journal.pone.0117119
Christensen, M. S.
, Vestergaard, J. M., d'Amore, F., Gørløv, J. S.
, Toft, G., Ramlau-Hansen, C. H., Stokholm, Z. A., Iversen, I. B., Nissen, M. S.
& Kolstad, H. A. (2018).
Styrene Exposure and Risk of Lymphohematopoietic Malignancies in 73,036 Reinforced Plastics Workers.
Epidemiology,
29(3), 342-351.
https://doi.org/10.1097/EDE.0000000000000819
Chan, F. C., Mottok, A., Gerrie, A. S., Power, M., Nijland, M., Diepstra, A., van den Berg, A.
, Kamper, P., d'Amore, F., d'Amore, A. L.
, Hamilton-Dutoit, S., Savage, K. J., Shah, S. P., Connors, J. M., Gascoyne, R. D., Scott, D. W. & Steidl, C. (2017).
Prognostic Model to Predict Post-Autologous Stem-Cell Transplantation Outcomes in Classical Hodgkin Lymphoma.
Journal of Clinical Oncology,
35(32), 3722-3733.
https://doi.org/10.1200/JCO.2017.72.7925
Cederleuf, H.
, Bjerregård Pedersen, M., Jerkeman, M., Relander, T.
, d'Amore, F. & Ellin, F. (2017).
The addition of etoposide to CHOP is associated with improved outcome in ALK+ adult anaplastic large cell lymphoma: A Nordic Lymphoma Group study.
British Journal of Haematology,
178(5), 739-746.
https://doi.org/10.1111/bjh.14740
Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., Dogan, A., Feldman, A. L., Fend, F., Friedberg, J. W., Gaulard, P., Ghia, P., Horwitz, S. M., King, R. L., Salles, G. ... Zelenetz, A. D. (2022).
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood,
140(11), 1229-1253.
https://doi.org/10.1182/blood.2022015851
Bro, M. L., Johansen, C.
, Vuust, P., Enggaard, L., Himmelstrup, B., Mourits-Andersen, T., Brown, P.
, d'Amore, F., Andersen, E. A. W., Abildgaard, N. & Gram, J. (2019).
Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
27(10), 3887-3896.
https://doi.org/10.1007/s00520-019-04666-8
Bouska, A., Zhang, W., Gong, Q., Iqbal, J., Scuto, A., Vose, J.
, Ludvigsen, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Delabie, J., Jaffe, E. S., Braziel, R. M., Connors, J. M. ... Chan, W. C. (2016).
Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma.
Leukemia,
31(1), 83-91.
https://doi.org/10.1038/leu.2016.175
Beck Enemark, M., Monrad, I., Madsen, C.
, Lystlund Lauridsen, K., Honoré, B., Plesner, T. L.
, Hamilton-Dutoit, S. J., d'Amore, F. & Ludvigsen, M. (2021).
PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation.
OncoTargets and Therapy,
14, 481-489.
https://doi.org/10.2147/OTT.S289337
Beck Enemark, M., Wolter, K., Campbell, A. J.
, Andersen, M. I. D., Sørensen, E. F., Hybel, T. E., Madsen, C.
, Lauridsen, K. L., Plesner, T. L.
, Hamilton-Dutoit, S. J., Honoré, B. & Ludvigsen, M. (2023).
Proteomics identifies apoptotic markers as predictors of histological transformation in patients with follicular lymphoma.
Blood Advances,
7(24), 7418-7432.
https://doi.org/10.1182/bloodadvances.2023011299
Bech, M. R., Baumgartner-Nielsen, J., Peterslund, N. A.
, Steiniche, T., Deleuran, M. & d'Amore, F. (2013).
Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus.
British Journal of Dermatology,
169(2), 469-72.
https://doi.org/10.1111/bjd.12324
Barrington, S. F., Kirkwood, A. A., Franceschetto, A., Fulham, M. J., Roberts, T. H., Almquist, H., Brun, E., Hjorthaug, K., Viney, Z. N., Pike, L. C., Federico, M., Luminari, S., Radford, J., Trotman, J., Fosså, A., Berkahn, L., Molin, D.
, D'Amore, F., Sinclair, D. A. ... Johnson, P. W. (2016).
PET-CT for staging & early response: results from 'Response Adapted Therapy in Advanced Hodgkin Lymphoma' (RATHL) (CRUK/07/033).
Blood.
https://doi.org/10.1182/blood-2015-11-679407
Barrenetxea Lekue, C., Grasso Cicala, S., Leppä, S., Stauffer Larsen, T., Herráez Rodríguez, S., Alonso Caballero, C.
, Jørgensen, J. M., Toldbod, H., Leal Martínez, I.
& D’Amore, F. (2019).
Pixantrone beyond monotherapy: a review.
Annals of Hematology,
98(9), 2025-2033.
https://doi.org/10.1007/s00277-019-03749-0
Antiga, E.
, Bech, R., Maglie, R., Genovese, G., Borradori, L., Bockle, B., Caproni, M., Caux, F., Chandran, N. S., Corrà, A.
, D'Amore, F., Daneshpazhooh, M., De, D., Didona, D., Dmochowski, M., Drenovska, K., Ehrchen, J., Feliciani, C., Goebeler, M. ... Marzano, A. V. (2023).
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV).
Journal of the European Academy of Dermatology & Venereology,
37(6), 1118-1134.
https://doi.org/10.1111/jdv.18931
Andersen, MP.
, Kamper, P., Nielsen, P. S., Bendix, K., Riber-Hansen, R.
, Steiniche, T., Hamilton-Dutoit, S. J., D'Amore, F. A. & Clausen, MR. (2013).
The number of tumour-infiltrating mast cells correlates with adverse prognosis in mixed cellularity, but not nodular sclerosis type, classical Hodgkin lymphoma.
Haematologica.
Andersen, R. K., Hammer, K.
, Hager, H., Christensen, J. N., Ludvigsen, M., Honoré, B., Thomsen, M.-B.
& Madsen, M. (2015).
Melanoma tumors frequently acquire LRP2/megalin expression, which modulates melanoma cell proliferation and survival rates. Pigment Cell & Melanoma Research.
https://doi.org/10.1111/pcmr.12352
Andersen, M. D.
, Nielsen, P. S., Bendix, K., Riber-Hansen, R.
, Steiniche, T., Hamilton-Dutoit, S., Clausen, M.
& d'Amore, F. (2015).
Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
European Journal of Haematology, 252-259.
https://doi.org/10.1111/ejh.12583
Andersen, M. N., Ludvigsen, M., Abildgaard, N., Petruskevicius, I., Hjortebjerg, R.
, Bjerre, M., Honoré, B., Møller, H. J. & Andersen, N. F. (2017).
Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.
OncoTargets and Therapy,
10, 1977-1982.
https://doi.org/10.2147/OTT.S124321
Andersen, M. D.
, Kamper, P., d’Amore, A., Clausen, M., Bentzen, H.
& d'Amore, F. (2018).
The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor†.
Leukemia and Lymphoma,
60(4), 927-933.
https://doi.org/10.1080/10428194.2018.1515939
Andersen, M. I. D., Hamilton-Dutoit, S., Modvig, L., Vase, M.
, Christiansen, I., Christensen, J. H., Dahl-Sørensen, R. B., Stoltenberg, D.
, Kamper, P. & d'Amore, F. (2022).
Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma: A study from the Danish Lymphoma Registry.
British Journal of Haematology,
198(1), 50-61.
https://doi.org/10.1111/bjh.18180
Amador, C., Greiner, T. C., Heavican, T. B., Smith, L. M., Galvis, K. T., Lone, W. G., Bouska, A.
, D'amore, F., Bjerregård Pedersen, M., Pileri, S. A., Agostinelli, C., Feldman, A. L., Rosenwald, A., Ott, G., Mottok, A., Savage, K. J., de Leval, L., Gaulard, P., Lim, S. T. ... Lymphoma/Leukemia Molecular Profiling Project (2019).
Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry.
Blood,
134(24), 2159-2170.
https://doi.org/10.1182/blood.2019000779
Agostinelli, C., Gallamini, A., Rigacci, L., Vitolo, U., Stracqualursi, L., Piccaluga, P., Stelitano, C., Patti, C., Argani, L., Broccoli, A., Levis, A.
, D'Amore, F. A., Zinzani, P. & Pileri, SA. (2011).
The prognostic value of biologic markers in classical Hodgkin Lymphoma (CHL) patients.
Annals of Oncology,
22(4), 206.